A Single Institution Study Evaluating the Fertility of Young Adults with Malignancy Treated with Immunotherapy and Early Referral to Oncofertility Providers - European Medical Journal

A Single Institution Study Evaluating the Fertility of Young Adults with Malignancy Treated with Immunotherapy and Early Referral to Oncofertility Providers

1 Mins
Oncology
Authors:
Jenny Gong , 1 Kathryn Coyne , 1 Matthew Mirsky , 1 Katherine Daunov , 1 Rebecca Flyckt , 1 * Iris Sheng 1
  • 1. University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA
*Correspondence to [email protected]
Disclosure:

The authors have declared no conflicts of interest.

Citation:
Oncol AMJ. ;2[1]:80-81. https://doi.org/10.33590/oncolamj/PGCJ5384.
Keywords:
Fertility, immunotherapy, oncofertility, young adults.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

BACKGROUND

Immune checkpoint inhibitors (ICI) are used to treat multiple types of cancer. However, there are limited studies on the long-term effects of ICI on fertility. This study seeks to examine factors influencing conception after treatment with ICI and referral rates to the authors’ oncofertility program.1

METHODS

A total of 184 female patients between the ages of 18–45 with malignancies were treated with ICI, from January 2012–December 2023, at a single tertiary medical center. Two patients were excluded due to limited reproductive data. Demographics, oncologic, fertility, and reproductive data were collected and analyzed.

RESULTS

Of the 184 patients, 68 (37.0%) had documented fertility discussions prior to ICI initiation, and 36 (19.6%) patients were referred to reproductive medicine. Of the referred patients, the median age at ICI initiation was 32 years, and 27 (75%) were White. The most common cancers included breast adenocarcinoma (52.8%), hematologic malignancies (25%), and melanoma (13.9%). Twenty-one (58.3%) underwent a fertility preservation cycle (oocyte or embryo cryopreservation). One patient received ovarian stimulation, but oocyte retrieval was not performed due to poor response. There were three patients with successful pregnancies (Table 1). All three were previously treated with nivolumab, and two also received chemotherapy. Of the three patients: one patient used IVF using frozen embryo transfer, to conceive, resulting in two full-term live births; the other two conceived via natural conception, each resulting in one full-term live birth. Time to conception ranged from 12–27 months following ICI completion.

Table 1: Reproductive data for individuals with successful conception following immune checkpoint inhibitors treatment.
FET: frozen embryo transfer; ICI: immune checkpoint inhibitors; mo: months.

CONCLUSION

Early referral to oncofertility providers in young adults with cancer can increase rates of successful conception and increase utilization of fertility preservation methods. Larger, multi-institutional studies are needed to further delineate the long- term effects of ICI on fertility.

References
Gong et al. A single institution study evaluating the fertility of young adults with malignancy treated with immunotherapy and early referral to oncofertility providers. J Clin Oncol. 2025;43:S16.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.